Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4752 |  LGVN Longeveron Inc. - Class A Common stock | 2.37 USD | -2.87% | -7.42% | -63.65% | +315.79% | 7.56 M USD | ||
| 4755 |  CURX Curanex Pharmaceuticals Inc - Common Stock | 4.76 USD | -1.04% | +1.28% | +14.42% | +534.67% | 7.46 M USD | ||
| 4756 |  SKYE Skye Bioscience, Inc. - Common Stock | 1.68 USD | +1.82% | +2.44% | -23.64% | +110.00% | 7.44 M USD | ||
| 4759 |  FBLG FibroBiologics, Inc. - Common Stock | 1.11 USD | -2.63% | -7.50% | -35.84% | +126.53% | 7.39 M USD | ||
| 4760 |  TRAW Traws Pharma, Inc. - Common Stock | 0.48 USD | 0.00% | -14.29% | -11.11% | -84.42% | 7.38 M USD | ||
| 4765 |  INM InMed Pharmaceuticals Inc. - Common Shares | 1.33 USD | 0.00% | -2.92% | +1.53% | -43.40% | 7.31 M USD | ||
| 4766 |  APRE Aprea Therapeutics, Inc. - Common Stock | 0.56 USD | -8.20% | -22.22% | -28.21% | -62.67% | 7.05 M USD | ||
| 4767 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.63 USD | +0.83% | +3.71% | -2.16% | -38.99% | 6.99 M USD | ||
| 4771 |  ENVB Enveric Biosciences, Inc. - Common Stock | 1.52 USD | +1.33% | +0.66% | +7.04% | -38.21% | 6.80 M USD | ||
| 4779 |  XCUR Exicure, Inc. - Common Stock | 1.01 USD | -0.98% | -13.68% | -28.37% | -82.59% | 6.61 M USD | ||
| 4780 |  ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.25 USD | -3.85% | -2.34% | -11.35% | -34.90% | 6.59 M USD | ||
| 4782 |  ALZN Alzamend Neuro, Inc. - Common Stock | 1.34 USD | -2.19% | -0.74% | -19.76% | -41.99% | 6.47 M USD | ||
| 4794 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 3.74 USD | -2.09% | -5.79% | +884.21% | +199.20% | 6.09 M USD | ||
| 4796 |  IMNN Imunon, Inc. - Common Stock | 1.07 USD | -4.46% | -20.74% | -35.54% | -67.08% | 6.00 M USD | ||
| 4803 |  KALA KALA BIO, Inc. - Common Stock | 0.30 USD | -16.67% | -26.83% | -46.43% | -80.52% | 5.80 M USD | ||
| 4808 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.86 USD | -2.27% | -6.52% | -18.10% | -75.29% | 5.67 M USD | ||
| 4812 |  PULM Pulmatrix, Inc. - Common Stock | 1.53 USD | +2.68% | -3.77% | +1.32% | -67.52% | 5.59 M USD | ||
| 4815 |  LEXX Lexaria Bioscience Corp. - Common Stock | 3.36 USD | -4.00% | +5.66% | -52.00% | +286.21% | 5.55 M USD | ||
| 4818 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.86 USD | -5.58% | -5.58% | -7.92% | -29.01% | 5.50 M USD | ||
| 4820 |  AIM AIM ImmunoTech Inc. Common Stock | 0.18 USD | 0.00% | -5.26% | -18.18% | -93.21% | 5.48 M USD |
Noticias Biotechnology Stocks
El fármaco de Pharvaris para el angioedema hereditario muestra alivio más rápido
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |